FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutical industry and concerns a dry powder preparation containing micronised: salmeterol xinafoate and fluticasone propionate. The preparation contains a carrier consisting of lactose of average particle size 100-120 mcm and sodium benzoate. What is also described is a method for producing the preparation.
EFFECT: formulation possesses higher percentage of a respirable fraction of the active substances.
4 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL INHALED MEDICATION FOR TREATMENT OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE LUNG DISEASE, CONTAINING MICRONISED TIOTROPIUM BROMIDE AS ACTIVE SUBSTANCE AND METHOD OF ITS PRODUCTION | 2012 |
|
RU2522213C2 |
| INHALATION PREPARATION FOR TREATING BRONCHAIL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2504382C1 |
| INHALATION PREPARATION FOR TREATING BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2510267C2 |
| AEROSOL COMBINATION OF SALMETEROL AND FLUTICASONE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2521975C1 |
| FILLER FOR CAPSULAR INHALER | 2016 |
|
RU2634258C1 |
| INHALATION PHARMACEUTICAL COMPOSITIONS IN FORM OF DRY POWDERS, SOLUTIONS AND SUSPENSIONS PREPARED THEREOF, AND METHOD FOR PREPARING THEM | 2006 |
|
RU2497507C2 |
| DRY POWDER COMPOSITIONS REPRESENTED AS PARTICLES WHICH CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATMENT OF OBSTRUCTIVE OR INFLAMMATORY DISEASES OF RESPIRATORY WAYS | 2012 |
|
RU2629333C2 |
| NEW DOSE AND FORMULATION | 2009 |
|
RU2608713C2 |
| HIGHLY DISPERSIVE PHARMACEUTICAL COMPOSITION OF BUDESONIDE WITH BETA-GLYCINE AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2539376C1 |
| COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | 2010 |
|
RU2586297C2 |
